Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -157.40% is 45% above its 2-year average of -285.40%, near the high end of its 2-year range (-1277.07%–-50.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.61% above its 12-month average of -195.79%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -157.40%.
RETURN ON INVESTED CAPITAL (ROIC)
-157.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-195.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.61%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.89%
median of 511 covered companies
CURRENT VS SECTOR MEDIAN
-426.60%
vs the sector median at left
eXoZymes, Inc.
Market Cap
$51.23M
Return on Invested Capital (ROIC)
-157.40%
TTM Avg
-195.79%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.71M
Return on Invested Capital (ROIC)
-96.37%
TTM Avg
-130.40%
3Y Avg
-89.09%
5Y Avg
-69.72%
Market Cap
$51.78M
Return on Invested Capital (ROIC)
-208.76%
TTM Avg
-1171.68%
3Y Avg
-1173.13%
5Y Avg
-939.08%
Market Cap
$50.51M
Return on Invested Capital (ROIC)
-2441.49%
TTM Avg
-1590.42%
3Y Avg
-842.10%
5Y Avg
-573.16%
Market Cap
$50.67M
Return on Invested Capital (ROIC)
13.63%
TTM Avg
32.98%
3Y Avg
9.79%
5Y Avg
24.14%
Market Cap
$49.84M
Return on Invested Capital (ROIC)
-109.13%
TTM Avg
-196.06%
3Y Avg
-152.48%
5Y Avg
-122.21%
Market Cap
$53.01M
Return on Invested Capital (ROIC)
-40.53%
TTM Avg
-31.24%
3Y Avg
-37.98%
5Y Avg
-33.19%
Market Cap
$52.80M
Return on Invested Capital (ROIC)
-38.04%
TTM Avg
-22.77%
3Y Avg
-89.18%
5Y Avg
-83.00%
Market Cap
$55.48M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-690.86%
3Y Avg
-402.79%
5Y Avg
-302.68%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.23M | -157.40% | -195.79% | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.71M | -96.37% | -130.40% | -89.09% | -69.72% |
| Envoy Medical, Inc. (COCH)vs › | $51.78M | -208.76% | -1171.68% | -1173.13% | -939.08% |
| Apollomics, Inc. (APLM)vs › | $50.51M | -2441.49% | -1590.42% | -842.10% | -573.16% |
| biote Corp. (BTMD)vs › | $50.67M | 13.63% | 32.98% | 9.79% | 24.14% |
| Clene Inc. (CLNN)vs › | $49.84M | -109.13% | -196.06% | -152.48% | -122.21% |
| ImageneBio Inc (IMA)vs › | $53.01M | -40.53% | -31.24% | -37.98% | -33.19% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | -38.04% | -22.77% | -89.18% | -83.00% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $55.48M | N/A | -690.86% | -402.79% | -302.68% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $53.99M | -136.77% | -80.48% | -75.99% | -77.22% |
ROIC
-157.4%
ROE
-278.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -157.40% |
| 2026-03-31 | -366.34% |
| 2025-12-31 | -220.60% |
| 2025-09-30 | -138.94% |
| 2025-06-30 | -95.67% |
| 2025-03-31 | -68.19% |
| 2024-12-31 | -50.70% |
| 2024-09-30 | -420.92% |
| 2024-06-30 | -186.46% |
| 2024-03-31 | -1277.07% |
| 2023-12-31 | -157.12% |
